We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00089284
Recruitment Status : Unknown
Verified April 2011 by Northwestern University.
Recruitment status was:  Active, not recruiting
First Posted : August 5, 2004
Last Update Posted : April 12, 2011
Information provided by:
Northwestern University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : December 2007
  Estimated Study Completion Date : April 2012